Sharon brings over 30 years of expertise in KOL management and pre-clinical/clinical market development in both start-ups and large medtech companies.  

Sharon was a co-founder of RadioTherapeutics and Vessix Vascular which was acquired Boston Scientific Corporation. She holds a BS in Health Science, and a Master’s in Public Health.